UBS ASSET MANAGEMENT AMERICAS INC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,118,911
-73.4%
279,222
-3.7%
0.00%
-83.3%
Q2 2023$11,730,5910.0%290,0740.0%0.01%0.0%
Q1 2023$11,730,591
-14.3%
290,074
-1.4%
0.01%
-14.3%
Q4 2022$13,684,417
-99.0%
294,162
+982.7%
0.01%
+600.0%
Q3 2022$1,409,256,000
+9.7%
27,1690.0%0.00%0.0%
Q2 2022$1,284,279,000
-3.3%
27,169
+45.6%
0.00%0.0%
Q1 2022$1,328,148,000
+29.8%
18,659
+36.4%
0.00%
Q4 2021$1,022,991,000
+46.0%
13,680
+10.9%
0.00%
Q3 2021$700,525,000
+29.1%
12,3310.0%0.00%
Q2 2021$542,687,000
-18.7%
12,331
-8.9%
0.00%
Q1 2021$667,645,000
+139.2%
13,537
+104.2%
0.00%
Q4 2020$279,123,000
-45.1%
6,630
-40.4%
0.00%
Q3 2020$508,846,000
-25.8%
11,115
-18.6%
0.00%
Q2 2020$685,568,000
-10.0%
13,654
-7.8%
0.00%
-100.0%
Q1 2020$761,936,000
-5.2%
14,815
+13.9%
0.00%
Q4 2019$803,387,000
+15.1%
13,004
+11.9%
0.00%
Q3 2019$698,070,000
-36.4%
11,619
-10.7%
0.00%
-100.0%
Q2 2019$1,097,279,000
-5.8%
13,004
+6.7%
0.00%0.0%
Q1 2019$1,164,293,000
+88.5%
12,189
+39.8%
0.00%0.0%
Q4 2018$617,638,000
-17.2%
8,720
-0.1%
0.00%0.0%
Q3 2018$745,810,000
-40.5%
8,727
-19.3%
0.00%0.0%
Q2 2018$1,253,458,000
+114.6%
10,815
+49.8%
0.00%
Q1 2018$584,170,000
+142.8%
7,220
+76.1%
0.00%
Q4 2017$240,588,0004,1000.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders